The Medication Experience of TB/HIV Coinfected Patients

Qualitative Study

Bibliographic Data

ID15460319
AuthorsNatália Helena de Resende (0000-0002-8553-1083, Universidade Federal de Minas Gerais, corresponding author), Ursula Martins (0000-0001-8616-7351, Universidade Federal de Minas Gerais), Ursula Carolina de Morais Martins (Universidade Federal de Minas Gerais), Djenane Ramalho De Oliveira (0000-0002-5548-8184, Universidade Federal de Minas Gerais), Dirce Inês Da Silva (0000-0002-3597-8063, Fundação Hospitalar do Estado de Minas Gerais), Silvana S De Miranda (0000-0001-7245-4472, Universidade Federal de Minas Gerais), Adriano Max Moreira Reis (0000-0002-0017-7338, Universidade Federal de Minas Gerais), Wânia Da Silva Carvalho (0000-0002-2575-6352, Universidade Federal de Minas Gerais), Simone De Araújo Medina Mendonça (0000-0001-5792-0682, Universidade Federal de Minas Gerais)
Year2022
Volume19
Issue22
Pages15153-15153
Publication date2022-11-17
Open AccessYes
TypeARTICLE
VenueInternational Journal of Environmental Research and Public Health (JOURNAL)
Journal identifiersISSN: 1661-7827 • E-ISSN: 1660-4601
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/ijerph192215153
PMID36429870
OpenAlexW4309607968
LanguageEN
Citations received3
References cited24

Tuberculosis (TB) and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) pharmacotherapy and the stigma related to both diseases are complex. The patients' subjective experiences with diseases and medications are of utmost importance in pharmaceutical care practice. This study aimed to understand the subjective medication experience of TB and HIV/AIDS coinfected patients. The study was based on descriptive research of a qualitative and quantitative nature using data collected during pharmaceutical care appointments and from medical records from September 2015 to December 2016 at a tertiary infectious diseases referral hospital in Southeastern Brazil. Data from 81 patients were analyzed. Regarding patient subjective medication experience, the following responses to the quantitative questionnaire were most frequent: preference for a route of administration (12.4%) and for non-pharmacological therapy (50.6%); concerns about price (11.1%) and adverse effects (18.5%); and association of a worsening of their health status with a change in medication dosage (23.5%). In the thematic analysis, adversity and socially constructed aspects were more prominent. Resolvability, associated with the patient's understanding of relief from signs and symptoms and health recovery, was observed; however, feelings of ambivalence permeated the other aspects, hence leading to treatment abandonment. The evaluation of patient medication experience can be a path to understanding and intervening in the phenomenon of treatment abandonment among TB and HIV/AIDS coinfected individuals

Abandonment (legal · Adverse effect · Ambivalence · Family medicine · Feeling · Human immunodeficiency virus (HIV · Pathology · Pharmacotherapy · Psychiatry · Qualitative research · Referral · Social stigma · Thematic analysis · Tuberculosis · HIV/AIDS Research and Interventions · Medicine · Pharmacological Effects and Toxicity Studies · Psychology · Tuberculosis Research and Epidemiology · Internal Medicine

Tools

Open DOIOpen Access